This is a complete copy of the IAOMT's addendum to their Petition for Reconsideration submitted by Jim Love, et al in March of 2013. The addendum to the petition added new proof of the damaging effect of mercury in amalgams and asked that mercury in dental materials either be banned or reclassified as an FDA Class III device thus restricting its use and increasing regulations when using this product.

Stephen M. Koral, DMD, FIAOMT writes an un-biased article that looks into commonly accepted variables concerning exposure, toxicology and risk assessment in the use of amalgam fillings in dentistry and the effect it will have on the use of amalgam in the future.

Michael Fleming DDS examines the role of the FDA concerning amalgam's use in dentistry. He also discusses common misconceptions and breaks down the arguments about amalgam's safety to their core components and examines them individually.

To the Honorable Prosecutor Ocampo. We are requesting you authorize an investigation by the International Criminal Court (ICC) into a crime against humanity under Article 7 of the Rome Statute directed at those responsible for the design, funding, execution, analysis, and publication of an unethical scientific experiment conducted on hundreds of children.  The experiment exposed the children to significant amounts of mercury, a deadly poison, in order to justify the use of dental amalgam fillings.

Researchers Dr. Mark and David Geier show how the data from the "children's amalgam trial" studies, originally published in the Journal of the American Medical Association, and purported to prove the safety of mercury amalgam, actually show a dose-dependent toxicity in a key metabolic system.

Mercury has been linked to Alzheimer's disease by a number of different studies that have accumulated over the last two decades. Watch and listen to published scientists talk about how mercury can cause many of the hallmarks of Alzheimer's disease. This article was taken from the IAOMT's Petition For Reconsideration, which prompted the FDA to re-evaluate their 2009 ruling that amalgam was safe for everyone.

Multiple Sclerosis (“MS”) was first commonly identified in the 19th century during the time in which mercury/silver fillings came into common use. There is toxicological evidence that mercury poisoning victims and multiple sclerosis victims share similar symptoms. While genetic variability and individual ability to excrete mercury probably plays a role, the causation of MS is probably multi-factorial. Very serious consideration should be given to mercury possibly playing a role in the etiology of MS. 

The current scientific debate regarding the safety of amalgam dental restorations being conducted in the US is presented. The material is based on a meeting held on December 14 and 15, 2010 by the Dental Products Panel of the Medical Devices Advisory Committee of the Food and Drug Administration. The scientific and historic context of the debate is provided, followed by scientific arguments, public testimony and panel deliberations.

In 1976, Congress directed FDA to classify (determine the risk of) every medical device. Dental fillings are a medical device. FDA proceeded to classify all filling materials except the most common one – and the most controversial one – mercury amalgam fillings. Despite letters, petitions, Congressional hearings, and a lawsuit, FDA refused to budge. FDA had no intention of doing what by law it was required to do. For 32 years, FDA defied the law.

Consumers for Dental Choice outlines a number of ways in which you can Take Action on the dental mercury filling issue. You can write to the director of FDA's Center for Devices, Jeff Shuren, This e-mail address is being protected from spambots. You need JavaScript enabled to view it Ask Dr Shuren why FDA continues to ignore the scientists and covers up the mercury from American parents and consumers. Ask when FDA is going to get in step with the world on mercury.

The FDA was charged with evaluating and classifying medical devices in 1976. Amalgam manufacturers have been able to successfully shirk the burden of proving safety, which should rightfully be assigned to them. If the FDA assigns the burden to prove harm to U.S. consumer groups, the FDA condemns itself to perpetual study and inaction. This will result in an ineffective agency and an unprotected public, devastated by preventable degenerative disease.

At an FDA Town Meeting (9-22-2011), injured consumers, dentists, and healthcare professionals will challenge the FDA to protect the public from “silver” dental amalgam fillings containing 50% mercury. Dr. Jeffrey Shuren, Director of the Center for Devices and Radiological Health, will host the meeting Sept 22, 8am-noon at the Embassy Suites Hotel, San Francisco Airport.